Distinguished Speaker Series | Robert MacLaren,MB,ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Fri, Feb 23 2024, 8:30 - 10am

Location

In person and on Zoom
GHEI building, UCI
3d floor, Cavanaugh Room A & B

Please register for the zoom link

Event Type

Add to Calendar: Outlook | Google | iCal

Description
Speakers

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

February 23, 2024 | Robert MacLaren,MB,ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Innovations in eye surgery

Learn More About the Distinguished Speaker Series

Featured

Robert MacLaren,MB,ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Professor of Ophthalmology, University of Oxford, England

Our clinical and laboratory research is dedicated to finding new treatments for blindness, particularly in patients with incurable retinal diseases, using stem cell-based approaches, gene therapy or electronic retinas. We are also developing new techniques for cataract and retinal surgery.

Our recent research achievements include:

2021: First demonstration of RNA silencing in vivo using self-cleaving mirtons applied to treat a dominantly inherited retinal degeneration (Nat Commun, 2021)
2020: Highest visual acuity ever recorded in a blind patient using a surgically implanted bionic eye, in collaboration with Retina Implant AG (Acta Ophthalmol, 2020)
2020: First gene therapy treatment available through the NHS following the NICE approval of Luxturna as a treatment for childhood blindness (BBC News).